Skip to content
Menu

Cardio Diagnostics Holdings, Inc. CDIOW

Full chart Compare
Set alert

Price alert · CDIOW

All alert types
0.01 USD 0.00 (-38.54%)

As ofNov 20, 2026, 3:13 PM EST

0.0059 Day range 0.0059
0.0059 52-week range 0.0059
YTD
0.00%
1 year
0.00%

 

No chart data for this range yet.
Market cap
1.47M
Revenue (ttm)
39.14K
YTD return
0.00%
1-year return
0.00%
Price / book
0.64
Revenue growth
356.20%
Volume
1.20K
Open
0.0189
Previous close
0.0096
Day's range
0.0059 – 0.0059
52-week range
0.0059 – 0.0059
Beta
4.68

Key statistics

Free cash flow
-5.92M
Total cash
1.31M
Total debt
870.45K
Return on equity
-293.27%

About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on CDIOW — it syncs with the Stock Master app.

Institution ownership

CDIOW institution ownership
Holder% heldSharesValueReported
Walleye Capital LLC7.23%234,90721.49KSep 29, 2024
Saba Capital Management, L.P.6.15%199,83918.29KSep 29, 2024
Walleye Trading LLC4.07%132,26512.10KSep 29, 2024
Clear Street LLC2.56%83,0427.60KSep 29, 2024
Context Capital Management, LLC2.51%81,5007.46KSep 29, 2024
Shaw D.E. & Co., Inc.2.30%74,8226.85KSep 29, 2024

Fund ownership

CDIOW fund ownership
Holder% heldSharesValueReported
Saba Capital Income & Opportunities Fd0.61%19,9331.82KJul 30, 2024